Intravenous peramivir vs oral oseltamivir in high‐risk emergency department patients with influenza: Results from a pilot randomized controlled study-Reference-Cited by-同舟云学术

Intravenous peramivir vs oral oseltamivir in high‐risk emergency department patients with influenza: Results from a pilot randomized controlled study

Published:2020-10-02 Issue:1 Volume:15 Page:121-131
ISSN:1750-2640
Container-title:Influenza and Other Respiratory Viruses
language:en
Short-container-title:Influenza Other Respi Viruses

Author:

Hsieh Yu‐Hsiang¹^ORCID,Dugas Andrea F.¹,LoVecchio Frank²,McBryde Breana¹,Ricketts Erin P.¹,Saliba‐Shaw Kathryn¹,Rothman Richard E.¹³

Affiliation:

1. Department of Emergency Medicine Johns Hopkins University School of Medicine Baltimore MarylandUSA

2. Department of Emergency Medicine University of Arizona College of Medicine Phoenix ArizonaUSA

3. Division of Infectious Diseases Johns Hopkins University School of Medicine Baltimore MarylandUSA

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,Pulmonary and Respiratory Medicine,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/irv.12794

Reference35 articles.

1. Centers for Disease Control and Prevention (CDC).Disease Burden of Influenza.https://www.cdc.gov/flu/about/disease/burden.htm. Accessed February 13 2020.

2. Using Clinical Research Networks to Assess Severity of an Emerging Influenza Pandemic

3. National Center for Immunization and Respiratory Diseases (NCIRD).Past Seasons Estimated Influenza Disease Burden.https://www.cdc.gov/flu/about/disease/burden.htm. Accessed February 13 2020.

4. Impact of Seasonal and Pandemic Influenza on Emergency Department Visits, 2003–2010, Ontario, Canada

5. RuiP KangK.National Hospital Ambulatory Medical Care Survey: 2015 Emergency Department Summary Tables.https://www.cdc.gov/nchs/data/nhamcs/web_tables/2015_ed_web_tables.pdf. Accessed December 11 2018.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antivirals for treatment of non-severe influenza: a systematic review and network meta-analysis of randomized controlled trials;2024-05-28

2. Retracted and republished from: “The current state of research on influenza antiviral drug development: drugs in clinical trial and licensed drugs”;mBio;2024-05-08

3. Viral Pneumonia: From Influenza to COVID-19;Seminars in Respiratory and Critical Care Medicine;2024-01-16

4. The current state of research on influenza antiviral drug development: drugs in clinical trial and licensed drugs;mBio;2023-10-31

5. Effects of bamlanivimab alone or in combination with etesevimab on subsequent hospitalization and mortality in outpatients with COVID-19: a systematic review and meta-analysis;PeerJ;2023-05-08